Search Results
May 21, 2026, 23:30 ET Mabwell Announces Latest Clinical Data on 9MW2821 to Be Presented at 2026 ASCO Annual Meeting as Oral and Poster Presentations
Fast Track Designation for three indications, Orphan Drug Designation for one indication, and Breakthrough Therapy Designation from the CDE of NMPA for two indications.Interim analysis for the Phase III clinical trials of urothelial carcinoma (UC) monotherapy, UC combination therapy and CC monotherapy
More news about: Mabwell
May 21, 2026, 23:05 ET ZPMC Launches Automated Production Line for Compact Enclosures
manufacturing flexibility, placing it among the more advanced production systems currently operating in China. The production line is built around two 5-axis machining centers and integrates a flexible manufacturing system (FMS) with an automated RGV (Rail Guided Vehicle) material handling system. Together,
More news about: ZPMC
May 21, 2026, 23:00 ET KT SAT Evolves into a 'Total Space Solution Provider' Presenting the Vision of "Space for Humanity"
concepts for defense aviation satellite solutionsA next-generation PNT (Positioning, Navigation, and Timing) business direction based on TWSTFT (Two-Way Satellite Time and Frequency Transfer), capable of operating in GNSS jamming and spoofing environmentsThe company drew significant attention
More news about: KT SAT
May 21, 2026, 22:52 ET Achieve earns top ranking for personal loan customer satisfaction from LendingTree
providing consumers with a clear path toward improving their financial health through debt consolidation."Earning a top-three spot on LendingTree for two consecutive quarters is a testament to our team's dedication to putting people first," said Achieve President of Lending Kyle Enright. "By combining
More news about: Achieve
May 21, 2026, 22:25 ET Sacred Heart Preparatory Graduates Its 128th Class
students will study in California, 88 will study out of state, and one will study internationally. One graduate will attend the U.S. Military Academy, two will attend California community colleges, one will attend vocational school, and three will pursue a gap year. Their academic goals represent a wide
More news about: Sacred Heart Schools, Atherton
May 21, 2026, 22:01 ET Lang Van Sues Hanoi's BH Media in U.S. Federal Court Over Alleged Piracy of 5,252 Vietnamese Sound Recordings
Vietnamese-American label's lawsuit, filed two weeks before USTR's April 30 designation of Vietnam as a "Priority Foreign Country," details ISRC metadata manipulation cited by USTR as a category of enforcement failure.WESTMINSTER, Calif., May
More news about: Lang Van, Inc.
May 21, 2026, 20:50 ET Microsoft and Black Tech Street Launch Greenwood Cyber + AI Lab in Tulsa
innovation to help organizations and communities better understand, adopt, and build with artificial intelligence technologies.The initiative includes two primary components:ASPIRE (AI Societal Program for Innovation, Research, and Education) — focused on expanding AI fluency, workforce development,
More news about: Black Tech Street
May 21, 2026, 20:29 ET ESENTIA Completes US $2 Billion Investment-Grade Bond Offering, Achieving Simultaneous Triple-Agency Rating on Inaugural Corporate Bond
("ESENTIA" or the "Company") today announced the successful settlement of US$2 billion senior unsecured 144A/Reg S notes offering. The transaction comprised two tranches: US$1.0 billion of 6.125% Notes due 2033 and US$1.0 billion of 6.500% Notes due 2038, both with bullet maturities. The offering was 4.5 times
More news about: Esentia
May 21, 2026, 20:00 ET Kelun-Biotech to Present Two Registrational Studies in the Oral Presentation Session on Non-Small Cell Lung Cancer at ASCO 2026
2026 /PRNewswire/ -- The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting will be held in Chicago from May 29 to June 2, local time. Two registrational studies of the trophoblast cell-surface antigen 2 (TROP2)-directed antibody drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT)(佳泰莱®)
More news about: Kelun-Biotech
May 21, 2026, 19:49 ET Toby Neugebauer Details Strategic Plan to Maximize Value for Fermi Shareholders During Today's Investor Presentation
powers.He was not terminated for cause. On April 17, the board terminated Mr. Neugebauer without cause. Fermi's attempt to remove him for cause two weeks later was legally invalid and is subject to pending litigation.The current board is using multiple legal tactics to suppress shareholder
More news about: Toby Neugebauer
May 21, 2026, 19:49 ET 2026 ASCO Abstract Highlights: Innovent Biologics' IBI363 (PD-1/IL-2α-bias bispecific fusion protein) Demonstrates Robust Survival Benefits in Long-Term Follow-up of PoC Study in Advanced Immunotherapy-Resistant Non-Small Cell Lung Cancer
Ib/II trials are evaluating IBI363 in NSCLC and CRC including the first-line and later line settings, and in additional tumor types. IBI363 has received two Fast Track Designations (FTD) from the U.S. FDA and three Breakthrough Therapy Designations (BTD) from China NMPA so far.In October 2025, Innovent
More news about: Innovent Biologics
May 21, 2026, 19:43 ET Brandi AI CEO Leah Nurik Warns AI-Written Marketing Content Is Weakening Brand Visibility in AI Search
should be."Why Generic AI-Written Content Weakens Brand Credibility and AI VisibilityNurik says generic AI-written content creates two related problems for marketing teams. First, it weakens brand credibility by replacing original insight, customer understanding and executive point of
More news about: Brandi AI
May 21, 2026, 19:25 ET Toby Neugebauer Details Strategic Plan to Maximize Value for Fermi Shareholders During Today's Investor Presentation
powers.He was not terminated for cause. On April 17, the board terminated Mr. Neugebauer without cause. Fermi's attempt to remove him for cause two weeks later was legally invalid and is subject to pending litigation.The current board is using multiple legal tactics to suppress shareholder
More news about: Toby Neugebauer
May 21, 2026, 18:55 ET ePlus Announces Fourth Quarter and Fiscal Year 2026 Earnings Release Date and Conference Call
8293082# (live call and replay)A replay of the call will be available approximately two hours after the call through June 4, 2026.About ePlus inc. ePlus is a customer-first, services-led, and results-driven industry
More news about: EPLUS INC.
May 21, 2026, 18:51 ET SIGGRAPH 2026 Explores the Convergence of Art, Science, and Technology
relocated to Tokyo, the work translates personal journeys into fragile material and participatory data portraiture across three components: "deportation", a two-hour performance where water drips onto washi paper printed with a life journey at a cadence driven by real-time worldwide searches for "deportation";
More news about: SIGGRAPH 2026
May 21, 2026, 18:47 ET Tharaldson Ethanol Increases Oil Recovery with New Technology
oil recovery at the plant further improving high protein production and high-quality DDGS. Tharaldson Ethanol successfully installed and is operating two Prodec 65 Oil Plus centrifuges as a trial project and, after six months of operation, the results met expectations to move forward with a full capital
More news about: Tharaldson Ethanol
May 21, 2026, 18:45 ET What drives multimillion-dollar medical claims? Sun Life report shows secondary health conditions, hospital stays and specialty drugs among key factors
reached this level, suggesting increases in severity as well as developments in therapies and treatments. Orthopedic/MSK conditions and cancer are also two of the most frequent diagnoses for short-term disability claims."We have a real opportunity to help people achieve meaningful, improved health
More news about: Sun Life U.S.
May 21, 2026, 18:40 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN
joining the class action]On May 15, 2026, Regeneron issued a press release disclosing that "results from the Phase 3 trial evaluating two dose levels of fianlimab (LAG-3 inhibitor) in combination with cemiplimab (PD-1 inhibitor) as a first-line treatment for patients with unresectable locally
More news about: Pomerantz LLP
May 21, 2026, 18:03 ET Coupa Acquires Tonkean to Accelerate Agentic Intake and Orchestration for Global Trade
Acquisition of AI-native intake and orchestration leader accelerates Coupa's ambition to power proprietary, two-sided, autonomous workflow automation for global buyers and suppliersFOSTER CITY, Calif., May 21, 2026
More news about: Coupa Software
May 21, 2026, 17:45 ET Coupa Acquires Tonkean to Accelerate Agentic Intake and Orchestration for Global Trade
Acquisition of AI-native intake and orchestration leader accelerates Coupa's ambition to power proprietary, two-sided, autonomous workflow automation for global buyers and suppliersFOSTER CITY, Calif., May 21, 2026
More news about: Coupa Software
May 21, 2026, 17:40 ET King Energy Celebrates Ribbon Cutting at The Shoppes at Chino Hills, Bringing Clean Energy to the Heart of the Community
local power grid, so there is a lot of complexity here," said Rob Porter, Chief Commercial Officer at King Energy. "The cumulative impact is close to two million kilowatt hours of emissions-free clean energy being generated and consumed on site by local businesses. Tenants here are saving money and using
More news about: King Energy
May 21, 2026, 17:34 ET Formosa Pharmaceuticals Announces Presentation of TSY-310 at the 2026 ASCO Annual Meeting
Society of Clinical Oncology (ASCO) Annual Meeting, to be held May 29 – June 2, 2026, in Chicago, Illinois. TSY-310 simultaneously targets EGFR and ROR1, two receptors frequently co-expressed in prevalent solid tumors. By leveraging a unique bispecific modality, TSY-310 optimizes target engagement and intracellular
More news about: Formosa Pharmaceuticals Inc.,
May 21, 2026, 17:30 ET Rutgers Cancer Institute and RWJBarnabas Health to Highlight Advances Shaping the Future of Cancer Research at the 2026 ASCO Annual Meeting
plus Chemotherapy (CHOP) in patients with previously untreated diffuse large B-cell lymphoma with high-risk features. Among 40 patients randomized to two dosing regimens, the safety profile was generally manageable and similar across groups. Findings show encouraging preliminary efficacy with no meaningful
More news about: Rutgers Cancer Institute and RWJBarnabas Health
May 21, 2026, 17:30 ET Canopy Studies Selected for Oral and Poster Presentations at 2026 ASCO Annual Meeting
Canopy, the leader in Enterprise AI for oncology, today announced two abstracts selected for presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. The studies demonstrate the potential of
More news about: Canopy
May 21, 2026, 17:17 ET Rigel Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting and EHA2026 Congress
abdominal discomfort, dark urine, or jaundice. Obtain baseline liver function tests prior to initiation of REZLIDHIA, at least once weekly for the first two months, once every other week for the third month, once in the fourth month, and once every other month for the duration of therapy. If hepatic dysfunction
More news about: Rigel Pharmaceuticals, Inc.